Greenberg Traurig and Intertox Present Report on Nanotechnology, Health and the Environment
June 11, 2010 05:12 PM US Eastern Timezone
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute’s Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010.
ANAHEIM, Calif.--(BUSINESS WIRE)--The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute’s Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc., a scientific consulting and research firm specializing in nanotechnology-related issues; and the chief executive officer of BPT Pharmaceuticals. It summarizes the nanotechnology-related efforts of U.S. government and industry regarding nanotechnology environmental, health and safety (EHS) policy.
Nanotechnology may substantially improve the quality of both human life and the natural environment, according to the authors of the report: Chinh H. Pham, Chair of Greenberg Traurig’s Nanotechnology Practice; Reed D. Rubinstein, Shareholder in the Environmental and Administrative Law Practice at Greenberg Traurig in Washington, D.C.; Dr. Richard C. Pleus, Managing Director of Intertox; and Lynn Foster, CEO of BPT Pharmaceuticals, who was previously at Greenberg Traurig. The EHS risks of nanotechnology require additional study. However, initial indications are that these risks are generally remote, speculative, and manageable, according to the report. It is now available for download at Nanotechnology - Greenberg Traurig, LLP.
About Greenberg Traurig, LLP
Greenberg Traurig, LLP is an international, full-service law firm with approximately 1800 attorneys serving clients from more than 30 offices in the United States, Europe and Asia. Greenberg Traurig’s Intellectual Property and Technology Practice is firmly positioned to provide strategic counsel for clients requiring in-depth understanding of both specialized technology and the complex dynamics of worldwide distribution. The firm has a strong bench of attorneys who understand the utilization of nanotechnology. For additional information, please visit www.gtlaw.com.
About Intertox, Inc.
Intertox is a scientific consulting and research firm passionate about achieving long-term solutions that protect public health. Headquartered in Seattle, WA, Intertox has been working in the nanomaterial industry to develop global health-protective standards and implementation practices. Intertox and Intertox’s sister company, Intertox Decision Sciences, provide analytical services and business risk assessments that both characterize and minimize nanomaterial risks. For additional information, please visit the firm's website at http://www.intertox.com.
Greenberg Traurig is a service mark and trade name of Greenberg Traurig, LLP and Greenberg Traurig, P.A.
©2010 Greenberg Traurig, LLP. Attorneys at Law. All rights reserved.